Home › Targets › CD40

CD40 (1 companies · 3 programs)

Companies with an active program directed at CD40.

Aptevo Therapeutics Inc. APVO

APVO711 Preclinical
APVO451 — Solid Tumors Preclinical
APVO452 — Prostate Cancer Preclinical